Brief: Cosmo Pharmaceuticals H1 Operating Profit Up At EUR 2.7 Mln

Cosmo NV

30/07/2020 06:13

July 30 (Reuters) - COSMO PHARMACEUTICALS NV  COPN.S :
    * H1 REVENUES EUR25.9M VERSUS EUR21.5M LAST YEAR
    * H1 OPERATING PROFIT EUR 2.7 MILLION VERSUS OPERATING LOSS
EUR
17.2 MILLION IN PRIOR PERIOD
    * WE ARE MAINTAINING OUR FY20 GUIDANCE OF REVENUE IN RANGE
OF
EUR52 TO EUR56M AND OPERATING PROFIT IN RANGE OF EUR2M TO EUR8M
    * H1 LOSS EUR 3.0 MILLION INCLUDING SHARE OF CASSIOPEA LOSS
EUR
2.2 MILLION

Source text for Eikon:  ID:nTENtgjlda 
Further company coverage:  COPN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))